| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
B, in Treatment of Corneal Alkali Burns in Mice




From the Departments of Ophthalmology* and Pathology,¶ Wakayama Medical University, Wakayama, Japan; the Department of Anatomy,
Graduate School of Medicine, Osaka City University, Osaka, Japan; the Laboratory of Cell Regulation and Carcinogenesis,
National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and the Department of Ophthalmology,
University of Cincinnati Medical Center, Cincinnati, Ohio
We evaluated the therapeutic efficacy of topical administration of SN50, an inhibitor of nuclear factor-
B, in a corneal alkali burn model in mice. An alkali burn was produced with 1 N NaOH in the cornea of C57BL/6 mice under general anesthesia. SN50 (10 µg/µl) or vehicle was topically administered daily for up to 12 days. The eyes were processed for histological or immunohistochemical examination after bromodeoxyuridine labeling or for semiquantification of cytokine mRNA. Topical SN50 suppressed nuclear factor-
B activation in local cells and reduced the incidence of epithelial defects/ulceration in healing corneas. Myofibroblast generation, macrophage invasion, activity of matrix metalloproteinases, basement membrane destruction, and expression of cytokines were all decreased in treated corneas compared with controls. To elucidate the role of tumor necrosis factor (TNF)-
in epithelial cell proliferation, we performed organ culture of mouse eyes with TNF-
, SN50, or an inhibitor of c-Jun N-terminal kinase (JNK) and examined cell proliferation in healing corneal epithelium in TNF-
/ mice treated with SN50. An acceleration of epithelial cell proliferation by SN50 treatment was found to depend on TNF-
/JNK signaling. In conclusion, topical application of SN50 is effective in treating corneal alkali burns in mice.
This article has been cited by other articles:
![]() |
K.-i. Miyazaki, Y. Okada, O. Yamanaka, A. Kitano, K. Ikeda, S. Kon, T. Uede, S. R. Rittling, D. T. Denhardt, W. W.-Y. Kao, et al. Corneal Wound Healing in an Osteopontin-Deficient Mouse Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1367 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yin, Z. Huang, B. Wu, Y. Shi, C. Cao, and Y. Lu Lornoxicam protects mouse cornea from UVB-induced damage via inhibition of NF-{kappa}B activation Br. J. Ophthalmol., April 1, 2008; 92(4): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitano, S. Saika, O. Yamanaka, K. Ikeda, Y. Okada, K. Shirai, and P. S. Reinach Emodin Suppression of Ocular Surface Inflammatory Reaction Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5013 - 5022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakao, Y. Hata, M. Miura, K. Noda, Y. N. Kimura, S. Kawahara, T. Kita, T. Hisatomi, T. Nakazawa, Y. Jin, et al. Dexamethasone Inhibits Interleukin-1{beta}-Induced Corneal Neovascularization: Role of Nuclear Factor-{kappa}B-Activated Stromal Cells in Inflammatory Angiogenesis Am. J. Pathol., September 1, 2007; 171(3): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, O. Yamanaka, Y. Okada, T. Miyamoto, A. Kitano, K. C. Flanders, Y. Ohnishi, Y. Nakajima, W. W.-Y. Kao, and K. Ikeda Effect of overexpression of ppar{gamma} on the healing process of corneal alkali burn in mice Am J Physiol Cell Physiol, July 1, 2007; 293(1): C75 - C86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, K. Ikeda, O. Yamanaka, K. C. Flanders, Y. Okada, T. Miyamoto, A. Kitano, A. Ooshima, Y. Nakajima, Y. Ohnishi, et al. Loss of Tumor Necrosis Factor {alpha} Potentiates Transforming Growth Factor {beta}-mediated Pathogenic Tissue Response during Wound Healing Am. J. Pathol., June 1, 2006; 168(6): 1848 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, K. Ikeda, O. Yamanaka, T. Miyamoto, Y. Ohnishi, M. Sato, Y. Muragaki, A. Ooshima, Y. Nakajima, W. W.-Y. Kao, et al. Expression of Smad7 in Mouse Eyes Accelerates Healing of Corneal Tissue after Exposure to Alkali Am. J. Pathol., May 1, 2005; 166(5): 1405 - 1418. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |